1. Home
  2. ODC vs URGN Comparison

ODC vs URGN Comparison

Compare ODC & URGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oil-Dri Corporation Of America

ODC

Oil-Dri Corporation Of America

HOLD

Current Price

$61.55

Market Cap

995.6M

ML Signal

HOLD

Logo UroGen Pharma Ltd.

URGN

UroGen Pharma Ltd.

HOLD

Current Price

$18.58

Market Cap

922.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ODC
URGN
Founded
1941
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
995.6M
922.1M
IPO Year
1994
2016

Fundamental Metrics

Financial Performance
Metric
ODC
URGN
Price
$61.55
$18.58
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$29.29
AVG Volume (30 Days)
60.2K
803.1K
Earning Date
06-19-2026
06-10-2026
Dividend Yield
1.31%
N/A
EPS Growth
50.45
N/A
EPS
1.69
N/A
Revenue
$485,572,000.00
$1,128,000.00
Revenue This Year
N/A
$119.37
Revenue Next Year
N/A
$64.79
P/E Ratio
$36.75
N/A
Revenue Growth
10.97
N/A
52 Week Low
$41.37
$3.42
52 Week High
$70.01
$30.00

Technical Indicators

Market Signals
Indicator
ODC
URGN
Relative Strength Index (RSI) 42.28 40.14
Support Level $60.61 $16.47
Resistance Level $63.41 $20.44
Average True Range (ATR) 2.78 1.40
MACD -0.81 -0.15
Stochastic Oscillator 9.35 13.79

Price Performance

Historical Comparison
ODC
URGN

About ODC Oil-Dri Corporation Of America

Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups, namely the Retail and Wholesale Products Group, which derives maximum revenue, and the Business-to-Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.

About URGN UroGen Pharma Ltd.

UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. Their flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with investigational candidate UGN-102 (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. Additionally, their immuno-uro-oncology pipeline includes UGN-301 (zalifrelimab), an anti-CTLA-4 antibody, intended for both monotherapy and combination therapy. Revenue is generated from product sales.

Share on Social Networks: